ALPS Group Inc Ordinary Share (NASDAQ:ALPS – Get Free Report) was the target of a significant decline in short interest in the month of June. As of June 30th, there was short interest totaling 14,273 shares, a decline of 39.3% from the June 15th total of 23,522 shares. Based on an average daily volume of 69,188 shares, the short-interest ratio is currently 0.2 days. Approximately 0.0% of the shares of the company are sold short.
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of ALPS Group Inc Ordinary Share in a research note on Monday, July 6th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.
View Our Latest Report on ALPS
ALPS Group Inc Ordinary Share Stock Performance
ALPS Group Inc Ordinary Share Company Profile
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
See Also
- Five stocks we like better than ALPS Group Inc Ordinary Share
- Which Storage Stock Is Best Positioned to Win the AI Memory War?
- Tesla’s Delivery Surprise Was Big—Earnings Need to Be Bigger
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
Receive News & Ratings for ALPS Group Inc Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Group Inc Ordinary Share and related companies with MarketBeat.com's FREE daily email newsletter.
